TWI250872B - Carbamate compounds for use in preventing or treating bipolar disorder - Google Patents
Carbamate compounds for use in preventing or treating bipolar disorder Download PDFInfo
- Publication number
- TWI250872B TWI250872B TW091103500A TW91103500A TWI250872B TW I250872 B TWI250872 B TW I250872B TW 091103500 A TW091103500 A TW 091103500A TW 91103500 A TW91103500 A TW 91103500A TW I250872 B TWI250872 B TW I250872B
- Authority
- TW
- Taiwan
- Prior art keywords
- group
- formula
- pharmaceutical composition
- mirror image
- image isomer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Emergency Medicine (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27168101P | 2001-02-27 | 2001-02-27 | |
| US10/081,766 US6562867B2 (en) | 2001-02-27 | 2002-02-21 | Carbamate compounds for use in preventing or treating bipolar disorder |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TWI250872B true TWI250872B (en) | 2006-03-11 |
Family
ID=26765948
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW091103500A TWI250872B (en) | 2001-02-27 | 2002-02-27 | Carbamate compounds for use in preventing or treating bipolar disorder |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6562867B2 (https=) |
| EP (1) | EP1408953B1 (https=) |
| JP (1) | JP4276837B2 (https=) |
| KR (1) | KR100946944B1 (https=) |
| CN (1) | CN1250215C (https=) |
| AT (1) | ATE324108T1 (https=) |
| BR (1) | BR0207644A (https=) |
| CA (1) | CA2439475C (https=) |
| CY (1) | CY1105330T1 (https=) |
| CZ (1) | CZ20032300A3 (https=) |
| DE (1) | DE60210976T2 (https=) |
| DK (1) | DK1408953T3 (https=) |
| ES (1) | ES2262801T3 (https=) |
| HU (1) | HUP0303243A3 (https=) |
| IL (1) | IL157590A0 (https=) |
| MX (1) | MXPA03007717A (https=) |
| MY (1) | MY129304A (https=) |
| NO (1) | NO20033802L (https=) |
| NZ (1) | NZ527988A (https=) |
| PL (1) | PL364638A1 (https=) |
| PT (1) | PT1408953E (https=) |
| RS (1) | RS50677B (https=) |
| RU (1) | RU2300372C2 (https=) |
| TW (1) | TWI250872B (https=) |
| WO (1) | WO2002067921A1 (https=) |
| ZA (1) | ZA200307465B (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ATE267629T1 (de) * | 2000-07-21 | 2004-06-15 | Ortho Mcneil Pharm Inc | Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen |
| EP1383489B1 (en) * | 2001-02-27 | 2007-05-09 | Ortho-Mcneil Pharmaceutical, Inc. | Carbamate compounds for use in preventing or treating neurodegenerative disorders |
| IL157594A0 (en) | 2001-02-27 | 2004-03-28 | Ortho Mcneil Pharm Inc | Carbamate compounds for use in preventing or treating anxiety disorders |
| ATE435014T1 (de) | 2001-07-16 | 2009-07-15 | Ortho Mcneil Pharm Inc | Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen |
| DK1809273T3 (da) * | 2004-09-16 | 2010-08-02 | Janssen Pharmaceutica Nv | Anvendelse af 2-phenyl-1,2-ethandiol-(di)carbamater til behandling af epileptogenese |
| EP1890684B1 (en) | 2005-06-08 | 2013-08-14 | SK Biopharmaceuticals Co., Ltd. | Treatment of sleep-wake disorders |
| US20070021501A1 (en) * | 2005-07-12 | 2007-01-25 | Twyman Roy E | Methods of treating epileptogenesis |
| EP2081648A2 (en) * | 2006-10-30 | 2009-07-29 | Janssen Pharmaceutica, N.V. | Carbamate compounds for use in treating depression |
| BRPI0718323A2 (pt) * | 2006-10-31 | 2013-11-26 | Janssen Pharmaceutica Nv | Tratamento de transtornos invasivos do desenvolvimento. |
| US8609849B1 (en) | 2010-11-30 | 2013-12-17 | Fox Chase Chemical Diversity Center, Inc. | Hydroxylated sulfamides exhibiting neuroprotective action and their method of use |
| CN105189451A (zh) * | 2013-03-12 | 2015-12-23 | 比皮艾思药物研发有限公司 | 氨基甲酸苯酯化合物和包含该化合物的用于预防或治疗神经性毒气引起的疾病的组合物 |
| US10195151B2 (en) | 2016-09-06 | 2019-02-05 | Jazz Pharmaceuticals International Iii Limited | Formulations of (R)-2-amino-3-phenylpropyl carbamate |
| MX2019006940A (es) * | 2016-12-14 | 2019-09-06 | Sk Biopharmaceuticals Co Ltd | Uso de compuestos de carbamato para prevencion, alivio o tratamiento del trastorno bipolar. |
| BR112019025286A2 (pt) | 2017-06-02 | 2020-06-23 | Jazz Pharmaceuticals Ireland Limited | Métodos e composições para tratamento de sonolência excessiva |
| US10940133B1 (en) | 2020-03-19 | 2021-03-09 | Jazz Pharmaceuticals Ireland Limited | Methods of providing solriamfetol therapy to subjects with impaired renal function |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3313692A (en) * | 1958-04-21 | 1967-04-11 | Armour Pharma | Method of inducing calming and muscle relaxation with carbamates |
| US3278380A (en) * | 1962-02-06 | 1966-10-11 | Armour Pharma | Methods of calming employing diphenyl hydroxy carbamate compounds |
| US3265728A (en) * | 1962-07-18 | 1966-08-09 | Armour Pharma | Substituted phenethyl carbamates |
| WO1995034563A1 (en) * | 1994-06-16 | 1995-12-21 | Pfizer Inc. | Pyrazolo and pyrrolopyridines |
| US5698588A (en) * | 1996-01-16 | 1997-12-16 | Yukong Limited | Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol |
-
2002
- 2002-02-21 ES ES02724984T patent/ES2262801T3/es not_active Expired - Lifetime
- 2002-02-21 PT PT02724984T patent/PT1408953E/pt unknown
- 2002-02-21 EP EP02724984A patent/EP1408953B1/en not_active Expired - Lifetime
- 2002-02-21 DK DK02724984T patent/DK1408953T3/da active
- 2002-02-21 RU RU2003128997/14A patent/RU2300372C2/ru active
- 2002-02-21 BR BR0207644-6A patent/BR0207644A/pt not_active Application Discontinuation
- 2002-02-21 IL IL15759002A patent/IL157590A0/xx not_active IP Right Cessation
- 2002-02-21 PL PL02364638A patent/PL364638A1/xx not_active Application Discontinuation
- 2002-02-21 CZ CZ20032300A patent/CZ20032300A3/cs unknown
- 2002-02-21 HU HU0303243A patent/HUP0303243A3/hu unknown
- 2002-02-21 DE DE60210976T patent/DE60210976T2/de not_active Expired - Lifetime
- 2002-02-21 WO PCT/US2002/005297 patent/WO2002067921A1/en not_active Ceased
- 2002-02-21 NZ NZ527988A patent/NZ527988A/en unknown
- 2002-02-21 KR KR1020037011296A patent/KR100946944B1/ko not_active Expired - Lifetime
- 2002-02-21 CN CNB028089170A patent/CN1250215C/zh not_active Expired - Fee Related
- 2002-02-21 US US10/081,766 patent/US6562867B2/en not_active Expired - Lifetime
- 2002-02-21 CA CA2439475A patent/CA2439475C/en not_active Expired - Fee Related
- 2002-02-21 JP JP2002567288A patent/JP4276837B2/ja not_active Expired - Lifetime
- 2002-02-21 AT AT02724984T patent/ATE324108T1/de active
- 2002-02-21 RS YUP-678/03A patent/RS50677B/sr unknown
- 2002-02-21 MX MXPA03007717A patent/MXPA03007717A/es active IP Right Grant
- 2002-02-27 TW TW091103500A patent/TWI250872B/zh active
- 2002-02-27 MY MYPI20020691A patent/MY129304A/en unknown
-
2003
- 2003-08-26 NO NO20033802A patent/NO20033802L/no not_active Application Discontinuation
- 2003-09-25 ZA ZA200307465A patent/ZA200307465B/en unknown
-
2006
- 2006-06-21 CY CY20061100844T patent/CY1105330T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TWI250872B (en) | Carbamate compounds for use in preventing or treating bipolar disorder | |
| TWI419681B (zh) | 胺基甲酸酯用於製造供治療白天過度嗜睡（eds）的藥物之用途 | |
| JP2024516421A (ja) | Ｍｄｍａ鏡像異性体 | |
| HU226138B1 (en) | R-enantiomer of n-propargyl-1-aminoindan, salts, compositions and uses thereof | |
| TWI331524B (en) | Carbamate compounds for use in preventing or treating movement disorders | |
| JP7429942B2 (ja) | テトラヒドロ－ｎ，ｎ－ジメチル－２，２－ジフェニル－３－フランメタンアミン（ａｎａｖｅｘ２－７３）のエナンチオマーならびにシグマ１レセプターにより調節されるアルツハイマー型および他の傷害の処置におけるその使用 | |
| JP4276839B2 (ja) | 双極性障害の予防もしくは治療における使用のためのカルバメート化合物 | |
| TWI304735B (en) | Carbamate compounds for use in the treatment of pain | |
| JP6768520B2 (ja) | 医療用の（ｓ）−ピルリンドールおよびその薬学的に許容可能な塩 | |
| MX2008000249A (es) | Combinaciones de eszopiclona y o-desmetilvenlafaxina y metodos de tratamiento de menopausia y trastornos del estado de animo, ansiedad y cognitivos. | |
| EP1401424B1 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| PT92799B (pt) | Utilizacao de um agonista parcial de glicina b, nomeadamente um composto amino-isoxazolidina, para a preparacao de um medicamento empregue como antipsicotico e processo para a preparacao de uma composicao farmaceutica contendo o referido agonista | |
| JP2023506480A (ja) | アルツハイマー病の治療のための化合物 | |
| AU2002242296A1 (en) | Carbamate compounds for use in preventing or treating psychotic disorders | |
| US20020147206A1 (en) | Combination treatment of multiple sclerosis (MS), other demyelinating conditions and peripheral neuropathy, especially painful neuropathies and diabetic neuropathy | |
| KR102693607B1 (ko) | 하지 불안 증후군을 치료하기 위한 치료제 | |
| JP2009539941A (ja) | Ｓｌｖ３０８およびｌ−ｄｏｐａを含んでなる組み合わせ製剤 | |
| TWI752282B (zh) | 苯甲酸或其鹽及衍生物用於預防或治療憂鬱症之用途 | |
| CA2585560C (en) | Use of acetyl l-carnitine for the treatment of fibromyalgic syndrome | |
| Lehmann | A new preparation for sedation in organic brain disease and senile disturbances. | |
| WO2023215338A1 (en) | Compositions and methods for treating cluster headache | |
| JP6216913B1 (ja) | 医薬組成物 | |
| WO2026080932A2 (en) | Compounds, compositions, and methods of use thereof | |
| JP2017088584A (ja) | 医薬組成物 | |
| WO2023215344A2 (en) | Compositions and methods for treating cluster-tic syndrome |